Clinical Trial Update: Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic Neuropathy [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating subcutaneous erythropoietin for improving visual functions in patients with late onset optic neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Optic Neuropathy

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Alexandria University | Conditions: Optic Neuropathy | Phase 1, Phase 2 | Status: COMPLETED